Nov 05, 2019 / 07:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Investor update at VIVA 2019 Conference Call. (Operator Instructions).
Also a reminder, today's teleconference is being recorded. At this time, I will turn the call over to your host, VP of Investor Relations, Ms. Susie Lisa. Please go ahead.
Susan Vissers Lisa - Boston Scientific Corporation - VP of IR
Thank you, Tony. And thanks, everyone, for joining us for VIVA update from our Peripheral Interventions team.
Good morning to those of you in Vegas, and good afternoon elsewhere here on the East Coast.
We'll start -- we'll jump right in, but I would first like to introduce our lineup, including Jeff Mirviss, whom you all know well, our Senior Vice President and President of our Peripheral Interventions business. He is joined by Cat Jennings, our VP of Marketing and Business Development. And then we have a new member of the team, I'm very pleased to introduce Dr. Michael Jaff, who is the incoming Vice President of Clinical Affairs, Innovation and
Boston Scientific Corp Investor Update at Vascular Interventional Advances Conference (VIVA) Transcript
Nov 06, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers